Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer

Author(s):
Charehbili, A.; Wasser, M.N.; Smit, V.T.H.B.M. (0000-0003-3730-5652); Putter, H.; Leeuwen-Stok, A.E. van; Kranenbarg, W.M.M.K.; Liefers, G.J.; Velde, C.J.H. van de (0000-0003-0104-1800); Nortier, J.W.R.; Kroep, J.R.
Published
2014
Publication type
Article / Letter to editor
Magnetic resonance imagingNeoadjuvant therapyBreast neoplasmsSurgery
Date issued
2014-10-31
Language
English
Is part of
EJSO - European Journal of Surgical Oncology (2014), Vol. 40, no. 10, p. 1216-1221
hdl
1887/108324
doi
10.1016/j.ejso.2014.07.036